Abstract:Aim Resistin and adiponectin are recently discovered protein hormones, which are produced and secreted by adipocytes. Nonalcoholic fatty liver disease (NAFLD) is a metabolic syndrome, which is associated with obesity. The aim of this study was to evaluate the changes of serum adiponectin and resistin in patients with NAFLD and to determine the relationship between serum adipokine levels and clinicopathologic parameters of NAFLD. Methods Forty-three patients with NAFLD and 43 controls were enrolled in this pair-matched study. Body weight height, body mass index, abdominal wall fat thickness, waist circumference, hip circumference, and the percentage of body fat were measured. Additionally, serum lipid, glucose, alanine aminotransferase, aspartate aminotransferase, adiponectin, and resistin were determined in all individuals. Serum adiponectin and resistin levels were determined using ELISA kits. Results Serum adiponectin levels were significantly lower in patients with NAFLD compared to the control group (control: 2.01 +/- 1.10 mg/l vs. NAFLD: 1.38 +/- 0.65 mg/l, P<0.01). Serum resistin levels were significantly elevated in patients with NAFLD compared to the control group (control: 4.70 +/- 3.30 ng/ml vs. NAFLD: 9.20 +/- 720 ng/ml, P<0.05). Serum adiponectin concentration was negatively correlated with the waist circumference (rho = -0.425), body mass index (rho = -0.329), percentage of body fat (rho = -0.256), abdominal wall fat thickness (rho = -0.226), and fasting blood glucose concentration (rho = -0.242), but was positively correlated with HDL (rho=0.226). Serum resistin concentration was positively correlated with waist circumference (rho=0.237). No correlation was found between resistin levels and blood pressure, fasting blood glucose concentration, triglyceride, total cholesterol, and HDL. Conclusion NAFLD patients had lower adiponectin levels and higher resistin levels. A positive correlation was found between resistin and waist circumference, whereas a negative correlation was found between adiponectin and waist circumference, body mass index, percentage of body fat, abdominal wall fat thickness, and fasting blood glucose concentration. These data suggested that hypoadiponectinemia and hyperresistinemia might be involved in the development of NAFLD. Eur J Gastroenterol Hepatol 21:662-666 (c) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

Expression of Adiponectin and Its Receptors in Livers of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.

[Nonalcoholic Steatohepatitis in Obese Children: the Prevalence and Possible Mechanism].

Correlation of Serum Adiponectin Level and Adiponectin Receptor Expression with Hepatic Pathological Changes in Rats with Non-Alcoholic Fatty Liver Diseases

Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels.

Expression of Adiponectin Receptor of Liver in Rats with Nonalcoholic Fatty Liver Disease

Association of Circulating Adipsin, Visfatin, and Adiponectin with Nonalcoholic Fatty Liver Disease in Adults: A Case-Control Study.

[The Relationship Between Insulin Resistance and Adiponectin Gene Expression in Nonalcoholic Fatty Liver Disease].

The Association Between Visceral Adipocyte Hypertrophy and NAFLD in Subjects with Different Degrees of Adiposity

Adiponectin and AdipoR with Nonalcoholic Steatohepatitis

The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis.

Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease

Hypoadiponectinemia is associated with Non-alcoholic fatty liver disease and metabolic syndrome

The Relationship Between Obesity and the Severity of Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis

A feasibility study of adiponectin to leptin ratio for severity of nonalcoholic fatty liver disease

Adiponectin Inhibits NLRP3 Inflammasome Activation in Nonalcoholic Steatohepatitis via AMPK-JNK/ErK1/2-NFκB/ROS Signaling Pathways

Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis

Relationship Between Adiponectin and Β-Cell Function and Insulin Resistance in Female Patients with Nonalcoholic Fatty Liver Disease

Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?

The Relationship Between Serum Adiponectin Level and Non-Alcoholic Fatty Liver Disease in Obese Children

Low Serum Adiponectin is a Predictor of Progressing to Nonalcoholic Fatty Liver Disease

Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study